FMR LLC 13D and 13G filings for Rubius Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 09:37 am Sale | 2023-04-06 | 13G | Rubius Therapeutics, Inc. RUBY | FMR LLC | 298,019 0.329% | -12,078,134 (-97.59%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Rubius Therapeutics, Inc. RUBY | FMR LLC | 12,376,153 13.694% | -1,103,713 (-8.19%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Rubius Therapeutics, Inc. RUBY | FMR LLC | 13,479,866 14.999% | 2,101,599 (+18.47%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Rubius Therapeutics, Inc. RUBY | FMR LLC | 11,378,267 14.060% | 2,210,975 (+24.12%) | Filing |
| 2020-02-07 11:28 am Purchase | 2020-02-06 | 13G | Rubius Therapeutics, Inc. RUBY | FMR LLC | 9,167,292 11.487% | 1,199,523 (+15.05%) | Filing |